Fibrocell Science Inc (FCSC)

[laltrader]

New Report 10/13: Periodontal Disease Market Forecast identifies Fibrocell as a key market player that will shape market in the next 5 years.

"The global periodontal disease market was evaluated at $1,248M in 2009:.... The influx of new drugs and the increase in the uptake of LAAs will the drive the market in the forecast period. The various phases of the developmental pipeline contain 19 molecules. Of these, only five are in Phase III and the rest are in the early stages of development. The pipeline consists of no new antibiotics.
The key market players covered are Kaken Pharmaceutical, Fibrocell Science, Inc., and Combinatorx, Inc.

http://www.researchandmarkets.com/reports/1212882/periodontal_disease_drug_pipeline_analysis_and